American Snuff Co. Recalls Kodiak Premium Wintergreen Tobacco

Business by 2FIRSTS.ai
Dec.19.2023
American Snuff Co. Recalls Kodiak Premium Wintergreen Tobacco
American Snuff Co., ASC voluntarily recalls batches of Kodiak Premium Wintergreen Longcut Tobacco sold in 18 states due to potential metallic contamination.

According to a report from Tobaccoreporter, American Snuff Co., ASC, is voluntarily recalling certain batches of Kodiak Premium Wintergreen Longcut Tobacco that were produced at their factory in Clarksville, Tennessee and sold in 18 states.

 

ASC has reported this voluntary recall incident to the US Food and Drug Administration and is working with the agency to address the issue.

 

According to a notice on the company's website, ASC has initiated a recall after discovering that certain batches of its products may contain metal foreign objects that may or may not be visible to consumers. The recall was prompted by a routine inspection which found issues with the production equipment, leading to wear and tear between metal components. This wear and tear could potentially result in metal fragments coming into contact with tobacco during the production process. So far, no products containing these foreign objects have been found, and the company has not received any consumer complaints or reports of consumer harm.

 

ASC's other products have not been affected, including other varieties of Kodiak, Grizzly, Hawken, and Cougar smokeless tobacco products, as well as all loose leaf, twisted, dry snuff, and plug products.

 

The American Smokeless Tobacco Company (ASC) has instructed wholesalers and retailers to separate the recalled Kodiak Premium Wintergreen Longcut tobacco from their inventory.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
Tamarind Intelligence’s decision to appoint a technology-sector executive as chief executive officer signals more than a leadership reshuffle at a specialist data firm. It reflects a broader structural shift across the global nicotine industry, where companies, regulators and intelligence providers are embedding artificial intelligence into core operations.
Special Report
Feb.18
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Dalton, Georgia considers new licensing rules and caps for vape shops
Dalton, Georgia considers new licensing rules and caps for vape shops
Dalton, Georgia is weighing a proposal to require city licenses for vape shops, limit how many can operate within city limits, and impose a 1,000-foot buffer for new shops from schools and other community facilities. City officials say the ordinance would not eliminate existing vape shops outright, though some may be impacted if ownership changes or licenses expire.
Feb.05 by 2FIRSTS.ai
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Goldman Sachs Managing Director Bonnie Herzog said the U.S. nicotine market is attractive and growing, with total revenue projected to reach about $67 billion by 2035. She expects cigarettes to account for a smaller share of revenue (47%) as smoke-free revenue expands and becomes a key driver of industry profit growth. Herzog said smoke-free products represent about 48% of U.S. nicotine volumes today and could rise to roughly 75% by 2035.
Mar.04 by 2FIRSTS.ai
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
Philip Morris International reported full-year 2025 results on February 6, with smoke-free products accounting for 41.5% of adjusted net revenues, up from 38.7% a year earlier. Total net revenues rose 7.3% to $40.65 billion, while shipment volumes increased 1.4%, widening the gap between revenue and volume growth. Cigarette shipments declined as smoke-free volumes rose 12.8%, driven by heated tobacco, oral nicotine and e-vapor products. Results were released alongside a 9:00 a.m. EST webcast.
Feb.06
Make Your Brand Understood by the People Who Matter
Make Your Brand Understood by the People Who Matter
Feb.02